Pyridostigmine bromide (PB) tablets
Pyridostigmine bromide (PB) is approved by the Food and Drug Administration (FDA) to be used as a pretreatment for exposure to the chemical nerve agent, soman. Common brand names: Mestinon, Regonol.
Availability: Commercially Available; with prescription
| Manufacturer |
| Alvogen |
| Product Name |
| Pyridostigmine bromide (PB) tablets |
| Detection Category |
| Chemical |
| Detection Method |
| Medical Countermeasure |
| Application |
| Personal Protective Equipment; |
| Equipment Type |
| PPE |
| Product Synopsis |
| Pyridostigmine bromide (PB) is approved by the Food and Drug Administration (FDA) to be used as a pretreatment for exposure to the chemical nerve agent, soman. Common brand names: Mestinon, Regonol. |
| Availability |
| Commercially Available; with prescription |
| Technology Readiness Level (TRL) |
| 9 |
| User Feedback Sources |
| Indifferent/No user feedback |
| Transportability |
| Pocket Size |
| Live Agent Tested |
| No |
| Material |
| Oral tablets in blister pack |
| Operating Time |
| Preventative administration prior to exposure |
| Standards Met |
| FDA |
| Training Required |
| <1 hour training |
| Manuals Available |
| Yes |
| Approved Vendors |
| Other Manufacturers: Amneal Pharmaceuticals LLC, Zydus Pharmaceuticals (USA) Inc., Rising Pharmaceuticals, Inc. |
